Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H de Thé

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Bulletin De L'Academie Nationale De Medecine|June 12, 1998
[Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?]H de Thé
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1995
[Acute promyelocytic leukemia: molecular aspects]H de Thé
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|October 6, 1998
[Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?]H de Thé
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1996
Altered retinoic acid receptorsH de Thé
Molecular Biology & Medicine|June 1, 1990
Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinomaA Dejean, H de Thé
Leukemia|June 22, 1999
In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodiesM Giannì, H de Thé
Bulletin Du Cancer|March 27, 1999
[PML (promyelocytic leukemia). Oncogene]T Soussi, H de Thé
Journal of the National Cancer Institute|May 18, 1999
Arsenic trioxide, a novel mitochondriotoxic anticancer agent?G Kroemer, H de Thé
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Molecular biology of the human foamy virusA Saïb, H de Thé
Cancer Surveys|January 1, 1992
Retinoic acid receptor alpha in acute promyelocytic leukaemiaH de Thé, A Dejean
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Bulletin De L'Academie Nationale De Medecine|June 12, 1998
[Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?]H de Thé
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1995
[Acute promyelocytic leukemia: molecular aspects]H de Thé
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|October 6, 1998
[Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?]H de Thé
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1996
Altered retinoic acid receptorsH de Thé
Molecular Biology & Medicine|June 1, 1990
Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinomaA Dejean, H de Thé
Leukemia|June 22, 1999
In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodiesM Giannì, H de Thé
Bulletin Du Cancer|March 27, 1999
[PML (promyelocytic leukemia). Oncogene]T Soussi, H de Thé
Journal of the National Cancer Institute|May 18, 1999
Arsenic trioxide, a novel mitochondriotoxic anticancer agent?G Kroemer, H de Thé
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Molecular biology of the human foamy virusA Saïb, H de Thé
Cancer Surveys|January 1, 1992
Retinoic acid receptor alpha in acute promyelocytic leukaemiaH de Thé, A Dejean
Pageof 10